TrialThe New England journal of medicine2017

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Hagop Kantarjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.